Back
Editas Medicine, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
36
EDIT
Editas Medicine, Inc.
Last Price:
$2.57
Seasonality Move:
-5.13%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing slight selling pressure.
Editas Medicine, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.49 | Buy |
| 20-day SMA: | 2.44 | Buy |
| 50-day SMA: | 2.95 | Sell |
| 200-day SMA: | 2.36 | Buy |
| 8-day EMA: | 2.48 | Buy |
| 20-day EMA: | 2.5 | Buy |
| 50-day EMA: | 2.4 | Buy |
| 200-day EMA: | 1.22 | Buy |
Editas Medicine, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 47.22 | Sell |
| Chaikin Money Flow: | 84316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 2.6) | Buy |
| Bollinger Bands (100): | (2.37 - 3.41) | Sell |
Editas Medicine, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Editas Medicine, Inc. Stock
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 2.51 while EDIT 8-day simple moving average is 2.49, which is a Buy signal.
-
The stock price of EDIT is 2.51 while Editas Medicine, Inc. 20-day SMA is 2.44, which makes it a Buy.
-
Editas Medicine, Inc. 50-day simple moving average is 2.95 while EDIT share price is 2.51, making it a Sell technically.
-
EDIT stock price is 2.51 and Editas Medicine, Inc. 200-day simple moving average is 2.36, creating a Buy signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
36
Editas Medicine, Inc. (EDIT)
is a Sell
Is Editas Medicine, Inc. a Buy or a Sell?
-
Editas Medicine, Inc. stock is rated a SellThe current Editas Medicine, Inc. [EDIT] share price is $2.51. The Score for EDIT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine, Inc. Stock Info
Market Cap:
245M
Price in USD:
2.51
Share Volume:
1.3M
Editas Medicine, Inc. 52-Week Range
52-Week High:
4.54
52-Week Low:
0.91
Sell
36
Editas Medicine, Inc. (EDIT)
is a Sell
Editas Medicine, Inc. Share Price Forecast
-
What is the Editas Medicine, Inc. stock price today?The Editas Medicine, Inc. stock price is 2.51 USD today.
-
Will EDIT stock go up or go down?Editas Medicine, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine, Inc. is overvalued.
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 2.51 while EDIT 8-day exponential moving average is 2.48, which is a Buy signal.
-
The stock price of EDIT is 2.51 while Editas Medicine, Inc. 20-day EMA is 2.50, which makes it a Buy.
-
Editas Medicine, Inc. 50-day exponential moving average is 2.40 while EDIT share price is 2.51, making it a Buy technically.
-
EDIT stock price is 2.51 and Editas Medicine, Inc. 200-day simple moving average is 1.22, creating a Buy signal.
Fundamental Analysis of Editas Medicine, Inc.
Is Editas Medicine, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.89 per share.
Technical Analysis of Editas Medicine, Inc.
Should I short Editas Medicine, Inc. stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Editas Medicine, Inc. is a Sell
-
Editas Medicine, Inc. Relative Strength Index (RSI) is 47.22, which suggest Editas Medicine, Inc. is oversold
-
The Bollinger Bands (25) for Editas Medicine, Inc. is (2.34 - 2.6), which suggest Editas Medicine, Inc. is a Sell
-
The Bollinger Bands (100) for Editas Medicine, Inc. is (2.37 - 3.41), which suggest Editas Medicine, Inc. is a Sell
* Editas Medicine, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.